Completed PHASE4 INTERVENTIONAL 2-arm NCT05616442

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

Sponsor: Tanta University

Updated 5 times since 2022 Last updated: Feb 4, 2026 Started: May 20, 2023 Primary completion: Mar 1, 2025 Completion: Mar 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hepatic Disease, this trial is completed. The trial is conducted by Tanta University and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE4

Status: Unknown → Completed
Dec 2024 — Feb 2026 [monthly]

Unknown PHASE4

Status: Not Yet Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
Dec 2022 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tanta University

Data source: Tanta University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tanta, Egypt